<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Access Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Access Microbiol</journal-id><journal-id journal-id-type="hwp">acmi</journal-id><journal-id journal-id-type="publisher-id">acmi</journal-id><journal-title-group><journal-title>Access Microbiology</journal-title></journal-title-group><issn pub-type="epub">2516-8290</issn><publisher><publisher-name>Microbiology Society</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12102499</article-id><article-id pub-id-type="publisher-id">001013.v3</article-id><article-id pub-id-type="doi">10.1099/acmi.0.001013.v3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="sub-display-channel"><subject>Antimicrobial Resistance</subject></subj-group><subj-group subj-group-type="sub-display-channel"><subject>Esbl</subject></subj-group><subj-group subj-group-type="sub-display-channel"><subject>Escherichia Coli</subject></subj-group><subj-group subj-group-type="sub-display-channel"><subject>Mobile Genetic Elements</subject></subj-group></article-categories><title-group><article-title>Derivatization of pBACpAK entrapment vectors for enhanced mobile genetic element transposition detection in multidrug-resistant Escherichia coli</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4445-8529</contrib-id><name><surname>Tansirichaiya</surname><given-names>Supathep</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp">*</xref><email>supathep.tan@mahidol.ac.th</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0007-3280-7625</contrib-id><name><surname>Leartsiwawinyu</surname><given-names>Wasawat</given-names></name><xref rid="aff1" ref-type="aff">1</xref><email>wasawat.lea@mahidol.ac.th</email></contrib><contrib contrib-type="author"><name><surname>Thanawan</surname><given-names>Nattharee</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><email>nattharee.th@gmail.com</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0008-0578-789X</contrib-id><name><surname>Goodman</surname><given-names>Richard N.</given-names></name><xref rid="aff3" ref-type="aff">3</xref><email>richard.goodman@lstmed.ac.uk</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0642-757X</contrib-id><name><surname>Tribuddharat</surname><given-names>Chanwit</given-names></name><xref rid="aff1" ref-type="aff">1</xref><email>chanwit.tri@mahidol.ac.th</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0760-3088</contrib-id><name><surname>Roberts</surname><given-names>Adam P.</given-names></name><xref rid="aff3" ref-type="aff">3</xref><email>adam.roberts@lstmed.ac.uk</email></contrib><aff id="aff1"><label>1</label><institution content-type="department">Department of Microbiology, Faculty of Medicine Siriraj Hospital</institution>, <institution>Mahidol University</institution>, <addr-line content-type="city">Bangkok</addr-line>, <country>Thailand</country></aff><aff id="aff2"><label>2</label><institution content-type="department">Army Institute of Pathology</institution>, <institution>Royal Thai Army Medical Department</institution>, <addr-line content-type="city">Bangkok</addr-line>, <country>Thailand</country></aff><aff id="aff3"><label>3</label><institution content-type="department">Department of Tropical Disease Biology</institution>, <institution>Liverpool School of Tropical Medicine</institution>, <addr-line content-type="city">Pembroke Place, Liverpool, L3 5QA</addr-line>, <country>UK</country></aff></contrib-group><author-notes><fn fn-type="COI-statement"><p>Adam P. Roberts is a Senior Editor for Access Microbiology. The other authors report no conflicts of interest.</p></fn><corresp id="cor1">Supathep Tansirichaiya, <email xlink:href="supathep.tan@mahidol.ac.th">supathep.tan@mahidol.ac.th</email></corresp><fn><p><bold>Supplementary material:</bold> Two supplementary figures and two supplementary tables are available with the online version of this article.</p></fn></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>5</month><year>2025</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>7</volume><issue>5</issue><elocation-id>001013.v3</elocation-id><history><date date-type="received"><day>26</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>08</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 The Authors</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="acmi-7-5-01013.pdf"/><abstract><title>Abstract</title><p><bold>Aim.</bold> Antimicrobial resistance poses a critical global health threat, driven by the dissemination of resistance genes via mobile genetic elements (MGEs). This study aims to enhance the detection of MGE insertions in multidrug-resistant <italic toggle="yes">Escherichia coli</italic> by derivatizing the pBACpAK entrapment vector.</p><p><bold>Methods and results.</bold> Three derivatives were constructed with additional nucleotides upstream of the <italic toggle="yes">cI</italic> repressor gene, based on conserved regions identified from GenBank sequences containing known IS<italic toggle="yes">26</italic> and IS<italic toggle="yes">1</italic> insertions. Using colony PCR, intracellular transposition screening was performed on 194 tetracycline-resistant colonies from four <italic toggle="yes">E. coli</italic> ESI123 strains carrying different pBACpAK constructs. The derivatives showed increased MGE capture rates (10.7&#x02013;73.1&#x0200a;%) compared to the WT vector (3.75%), identifying multiple MGEs, including the novel composite transposon Tn<italic toggle="yes">7824</italic>. Tn<italic toggle="yes">7824</italic> harbours the <italic toggle="yes">bla</italic><sub>OXA-181</sub> carbapenem resistance gene and the <italic toggle="yes">qnrS1</italic> quinolone resistance gene, highlighting the clinical relevance of these findings. Long-read sequencing of transposants confirmed the accuracy of MGE identification and structural characterization, which also revealed chromosomal integration events of the pBACpAK derivatives mediated by flanking insertion sequences.</p><p><bold>Conclusions.</bold> The modifications introduced in the pBACpAK derivatives could increase the detection of transposition events by alleviating spatial constraints, allowing for more robust MGE detection.</p></abstract><kwd-group><kwd>antimicrobial resistance</kwd><kwd><italic toggle="yes">Escherichia coli</italic></kwd><kwd>insertion sequences</kwd><kwd>mobile genetic elements</kwd><kwd>pBACpAK entrapment vector</kwd><kwd>transposons</kwd></kwd-group><funding-group><award-group><funding-source>
<institution-wrap><institution-id>http://dx.doi.org/10.13039/100014013</institution-id></institution-wrap>
<institution>UK Research and Innovation</institution>
</funding-source><award-id>MR/W030578/1</award-id><principal-award-recipient>
<name><surname>P. Roberts</surname><given-names>Adam</given-names></name>
</principal-award-recipient></award-group><award-group><funding-source>
<institution-wrap><institution-id>http://dx.doi.org/10.13039/501100024597</institution-id></institution-wrap>
<institution>Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation, Thailand</institution>
</funding-source><award-id>RGNS 65-156</award-id><principal-award-recipient>
<name><surname>Tansirichaiya</surname><given-names>Supathep</given-names></name>
</principal-award-recipient></award-group></funding-group></article-meta></front><body><boxed-text id="BX1" position="float"><caption><title>Impact Statement</title></caption><p>These findings highlight the utility of entrapment vectors for studying mobile genetic element (MGE)-associated antimicrobial resistance (AMR) dissemination in clinical and environmental settings. By improving the detection of novel and clinically relevant MGEs, such as Tn<italic toggle="yes">7824</italic>, this approach contributes to a better understanding of resistance gene mobility and may aid future AMR surveillance efforts.</p></boxed-text><sec sec-type="data-availability" id="s1"><title>Data Availability</title><p>All whole-genome sequencing data generated in this study have been deposited in the National Center for Biotechnology Information GenBank under BioProject ID PRJNA1224291. The accession numbers for each isolate (SAMN46856268 to SAMN46856290) in this BioProject are provided in Table S2. The sequences of Tn<italic toggle="yes">7824</italic> and the pBACpAK derivatives have been deposited under accession numbers PV132339 and PV591341-PV591343, respectively.</p></sec><sec sec-type="intro" id="s2"><title>Introduction</title><p>Antimicrobial resistance (AMR) poses a significant global public health challenge, with an estimated 1.27&#x02009;million deaths attributed to resistant bacterial infections in 2019, surpassing mortality rates from human immunodeficiency virus (HIV)/AIDS and malaria [<xref rid="R1" ref-type="bibr">1</xref>]. Recent projections estimated that by 2050, antimicrobial resistance could lead to ~1.91&#x02009;million deaths attributable to AMR and 8.22&#x02009;million deaths associated with AMR annually [<xref rid="R2" ref-type="bibr">2</xref><xref rid="R3" ref-type="bibr">3</xref>]. The pervasive use of antimicrobials across sectors such as healthcare, agriculture and veterinary medicine exerts selective pressure, driving the development and dissemination of AMR among bacterial populations [<xref rid="R4" ref-type="bibr">4</xref><xref rid="R5" ref-type="bibr">5</xref>]. Nosocomial infections by the ESKAPEE pathogen group are notorious for causing severe, prolonged outbreaks in clinical settings due to their resistance to multiple antibiotic classes. For example, <italic toggle="yes">Escherichia coli</italic> alone accounted for ~800,000 AMR-related deaths in 2019 [<xref rid="R1" ref-type="bibr">1</xref>]. The World Health Organization has categorized carbapenem-resistant and third-generation cephalosporin-resistant <italic toggle="yes">Enterobacteriaceae</italic>, including <italic toggle="yes">E. coli</italic>, as critical priority pathogens due to the urgent need for the development of new antibiotics to combat these highly resistant bacteria [<xref rid="R6" ref-type="bibr">6</xref>].</p><p>A crucial factor in the accumulation and spread of antibiotic resistance genes (ARGs) in pathogens is the activity of mobile genetic elements (MGEs), which are segments of DNA capable of movement within and between genomes. Conjugative plasmids and transposons facilitate the intercellular transfer of ARGs, while insertion sequences (ISs) and transposons enable intracellular transposition between and within replicons within the same cell. Notable MGEs carrying ARGs against last-resort antibiotics have been identified in <italic toggle="yes">E. coli</italic>, such as the Tn<italic toggle="yes">3000</italic> composite transposon carrying the <italic toggle="yes">bla</italic><sub>NDM-1</sub> carbapenem resistance gene [<xref rid="R7" ref-type="bibr">7</xref>] and the IS<italic toggle="yes">Apl1</italic> composite transposon with the <italic toggle="yes">mcr-1</italic> colistin resistance gene [<xref rid="R8" ref-type="bibr">8</xref>].</p><p>To manage AMR efficiently, the identification and characterization of ARG-carrying MGEs are crucial. Traditionally, MGEs are identified through phenotypic changes conferred by accessory genes like ARGs or by comparative analysis of whole-genome sequencing (WGS) data against existing databases. However, these methods fall short in providing information on MGE transposition and face challenges in contextualizing ARGs within functional MGEs from short-read sequencing data, particularly when multiple similar MGE copies are present in bacterial genomes.</p><p>Another method involves using entrapment vectors to capture MGEs based on their transposition activity. These vectors include a genetic system that confers a selective phenotype when MGEs transpose into a specific DNA region [<xref rid="R9" ref-type="bibr">9</xref>]. Previously, a single copy number entrapment vector has been developed called pBACpAK, demonstrating its ability to detect MGE insertions in both laboratory and clinical <italic toggle="yes">E. coli</italic> isolates [<xref rid="R10" ref-type="bibr">10</xref><xref rid="R12" ref-type="bibr">12</xref>]. The pBACpAK vector contains a <italic toggle="yes">cI-tetA</italic> gene system, where the &#x003bb; repressor (encoded by <italic toggle="yes">cI</italic>) constitutively inhibits the expression of the <italic toggle="yes">tetA</italic> gene by binding to the P<sub>RM</sub> promoter, blocking <italic toggle="yes">tetA</italic> expression. When an MGE inserts into the <italic toggle="yes">cI</italic> gene, it disrupts the repressor&#x02019;s expression, leading to the expression of <italic toggle="yes">tetA</italic> and resulting in a selectable tetracycline resistance phenotype, which allows for the detection of rare transposition events within large populations of bacteria. Derivatives of pBACpAK were also developed by replacing the selective marker from <italic toggle="yes">catA1</italic> resistance gene with <italic toggle="yes">mcr-1</italic> in pBACpAK-COL and <italic toggle="yes">aph(3&#x02032;)-Ia</italic> in pBACpAK-KAN, allowing the detection of transposition in a wider range of clinical isolates by circumventing their existing resistance profiles [<xref rid="R13" ref-type="bibr">13</xref>]. This approach allowed the capture of multiple IS elements, novel transposons and a novel translocatable unit.</p><p>In this study, we aim to enhance the detection of MGEs in multidrug-resistant <italic toggle="yes">E. coli</italic> clinical isolates by derivatizing the original pBACpAK vector. This was achieved by adding additional nucleotides between the <italic toggle="yes">cI</italic> repressor and <italic toggle="yes">tetA</italic> genes, based on the common target sequences observed at IS<italic toggle="yes">1</italic> and IS<italic toggle="yes">26</italic> insertion sites in sequences deposited in GenBank. Both IS elements are among the most prevalent IS elements associated with ARGs in clinical multidrug-resistant <italic toggle="yes">E. coli</italic> [<xref rid="R14" ref-type="bibr">14</xref><xref rid="R16" ref-type="bibr">16</xref>]. This approach is designed to improve our understanding of MGE transposition dynamics and contribute to the broader effort of combating AMR. By increasing the detection sensitivity for MGE transposition, we hope to gain deeper insights into their role in the dissemination of resistance genes among pathogenic bacteria and to be able to utilize them as tools.</p></sec><sec sec-type="methods" id="s3"><title>Methods</title><sec id="s3-1"><title>Bacterial strains, plasmids and culture conditions</title><p>All bacterial strains used in this study are listed in <xref rid="T1" ref-type="table">Table 1</xref>. These strains were cultured at 37&#x02009;&#x000b0;C in Luria&#x02013;Bertani (LB) medium with appropriate antibiotics (Sigma-Aldrich, Thailand), with the concentrations of antibiotics as follows: chloramphenicol at 12.5&#x02009;&#x000b5;g&#x02009;ml<sup>&#x02212;1</sup>, ampicillin at 100&#x02009;&#x000b5;g&#x02009;ml<sup>&#x02212;1</sup> and tetracycline at 10&#x02009;&#x000b5;g&#x02009;ml<sup>&#x02212;1</sup>. The extended-spectrum <italic toggle="yes">&#x003b2;</italic>-lactamase (ESBL) <italic toggle="yes">E. coli</italic> ESI123 clinical isolate was obtained from the routine bacteriology laboratory at Siriraj Hospital, Bangkok, Thailand. The sequence type of <italic toggle="yes">E. coli</italic> ESI123 was identified using the Achtman scheme via PubMLST [<xref rid="R17" ref-type="bibr">17</xref>], and the putative pathovar was inferred based on the presence of virulence-associated genes using VirulenceFinder 2.0 [<xref rid="R18" ref-type="bibr">18</xref>]. Siriraj Hospital Institutional Review Board (IRB) reviewed this study and confirmed that ethical approval was not required as it is classified as non-human subject research. The protocols in this study were approved for biosafety by the Siriraj Safety and Risk Management Taskforce of Mahidol University (SI2023-006).</p><table-wrap position="float" id="T1"><label>Table 1.</label><caption><title>Bacterial strains used in this study</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" rowspan="1" colspan="1">Strain</th><th align="left" valign="top" rowspan="1" colspan="1">Characteristic</th><th align="left" valign="top" rowspan="1" colspan="1">Resistance phenotype*</th><th align="center" valign="top" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Bacterial strains</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic toggle="yes">E. coli</italic> DH5&#x003b1;</td><td align="left" valign="top" rowspan="1" colspan="1">- Chemically competent cells</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="top" rowspan="1" colspan="1">New England Biolabs</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic toggle="yes">E. coli</italic>::pBACpAK-WT</td><td align="left" valign="top" rowspan="1" colspan="1">- <italic toggle="yes">E. coli</italic> MDS strain containing the original pBACpAK entrapment vector from the previous study</td><td align="left" valign="top" rowspan="1" colspan="1">Chl<sup>R</sup></td><td align="center" valign="top" rowspan="1" colspan="1">[<xref rid="R10" ref-type="bibr">10</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic toggle="yes">E. coli</italic> ESI123</td><td align="left" valign="top" rowspan="1" colspan="1">- Clinical strain isolated in 2021</td><td align="left" valign="top" rowspan="1" colspan="1">Amp<sup>R</sup></td><td align="center" valign="top" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic toggle="yes">E. coli</italic> ESI123::pBACpAK-WT</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">- E. coli</italic> ESI123 containing pBACpAK-WT</td><td align="left" valign="top" rowspan="1" colspan="1">Chl<sup>R</sup>, Amp<sup>R</sup></td><td align="center" valign="top" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic toggle="yes">E. coli</italic> ESI123::pBACpAK-16bp-3Prime</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">- E. coli</italic> ESI123 containing pBACpAK-16bp-3Prime</td><td align="left" valign="top" rowspan="1" colspan="1">Chl<sup>R</sup>, Amp<sup>R</sup></td><td align="center" valign="top" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic toggle="yes">E. coli</italic> ESI123::pBACpAK-16bp-5Prime</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">- E. coli</italic> ESI123 containing pBACpAK-16bp-5Prime</td><td align="left" valign="top" rowspan="1" colspan="1">Chl<sup>R</sup>, Amp<sup>R</sup></td><td align="center" valign="top" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic toggle="yes">E. coli</italic> ESI123::pBACpAK-26bp</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">- E. coli</italic> ESI123 containing pBACpAK-26bp</td><td align="left" valign="top" rowspan="1" colspan="1">Chl<sup>R</sup>, Amp<sup>R</sup></td><td align="center" valign="top" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Plasmids</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;pBACpAK-WT</td><td align="left" valign="top" rowspan="1" colspan="1">- Entrapment vector from previous study</td><td align="left" valign="top" rowspan="1" colspan="1">Chl<sup>R</sup></td><td align="center" valign="top" rowspan="1" colspan="1">[<xref rid="R11" ref-type="bibr">11</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;pBACpAK-16bp-3Prime</td><td align="left" valign="top" rowspan="1" colspan="1">- pBACpAK vector with the addition of 16&#x02009;bp derived from the 3&#x02032; end of the curated IS<italic toggle="yes">26</italic> insertion sites</td><td align="left" valign="top" rowspan="1" colspan="1">Chl<sup>R</sup></td><td align="center" valign="top" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;pBACpAK-16bp-5Prime</td><td align="left" valign="top" rowspan="1" colspan="1">- pBACpAK vector with the addition of 16&#x02009;bp derived from the 5&#x02032; end of the curated IS<italic toggle="yes">26</italic> insertion sites</td><td align="left" valign="top" rowspan="1" colspan="1">Chl<sup>R</sup></td><td align="center" valign="top" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;pBACpAK-26bp</td><td align="left" valign="top" rowspan="1" colspan="1">- pBACpAK vector with the addition of 26&#x02009;bp derived from the 3&#x02032; end of the curated IS<italic toggle="yes">1</italic> insertion sites</td><td align="left" valign="top" rowspan="1" colspan="1">Chl<sup>R</sup></td><td align="center" valign="top" rowspan="1" colspan="1">This study</td></tr></tbody></table><table-wrap-foot><fn id="T1_FN1" fn-type="other"><p>*ChlR, chloramphenicol resistance; AmpR, ampicillin resistance.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-2"><title>Construction of the MGE-targeted pBACpAK entrapment vectors</title><p>A series of entrapment vectors was constructed based on the pBACpAK vector to capture MGEs of interest. This was done by adding the putative target sites of MGEs associated with ARGs from the selected clinical isolates between the <italic toggle="yes">cI</italic> and <italic toggle="yes">tetA</italic> genes of pBACpAK (<xref rid="F1" ref-type="fig">Fig. 1</xref>). The insertion sites for each MGE were identified by curating sequences flanking the MGEs of interest from the GenBank DNA database. These sequences were then aligned using <sc>clustal omega</sc> [<xref rid="R19" ref-type="bibr">19</xref>] to determine the putative consensus insertion sites for each MGE through WebLogo [<xref rid="R20" ref-type="bibr">20</xref>].</p><fig position="float" id="F1" fig-type="figure"><label>Fig. 1.</label><caption><title>pBACpAK and location for constructing the pBACpAK derivatives. The <italic toggle="yes">cI</italic> repressor, chloramphenicol, tetracycline and other genes are represented by yellow, orange, blue and black open-arrowed boxes, respectively. The additional nucleotides were added at the start of the <italic toggle="yes">cI</italic> repressor gene, indicated by the purple boxes. The red arrows indicate the positions and orientations of the primers used for colony PCR: <italic toggle="yes">cI-tetA</italic>-F1 (forward) and ERIS (reverse), which amplify the region from the end of the <italic toggle="yes">c</italic>I repressor gene to the start of <italic toggle="yes">tetA</italic>.</title></caption><graphic xlink:href="acmi-7-01013-g001" position="float"/></fig><p>The MGE insertion site sequences were incorporated between the <italic toggle="yes">cI</italic> and <italic toggle="yes">tetA</italic> genes of pBACpAK via site-directed mutagenesis (<xref rid="F1" ref-type="fig">Fig. 1</xref>). Target sequences and a NheI restriction site (GCTAGC) were added to the forward and reverse primers designed using NEBaseChanger. PCR was performed using pBACpAK as a DNA template. The resulting PCR amplicons were treated with a kinase&#x02013;ligase&#x02013;DpnI (KLD) enzyme mix and then transformed into <italic toggle="yes">E. coli</italic> DH5&#x003b1; competent cells. Clones with the MGE-targeted-pBACpAK were confirmed by NheI digestion and Sanger sequencing across the target site between the <italic toggle="yes">cI</italic> and <italic toggle="yes">tetA</italic> genes.</p></sec><sec id="s3-3"><title>Preparation and electroporation of <italic toggle="yes">E. coli</italic> electrocompetent cells</title><p><italic toggle="yes">E. coli</italic> clinical isolates were prepared as electrocompetent cells following a previously described protocol [<xref rid="R21" ref-type="bibr">21</xref>]. An overnight culture was grown in LB broth supplemented with ampicillin (selective markers for ESBL<italic toggle="yes">&#x02013;E. coli</italic> clinical isolates) and chloramphenicol (a selective marker for pBACpAK). This overnight culture was then diluted to an OD<sub>600</sub> of 0.05 in a flask containing 50&#x02009;ml of LB broth and incubated until it reached the mid-exponential phase (OD<sub>600</sub> of 0.6). The culture was split into two 50-ml tubes and incubated on ice for 10&#x02009;min. Cells were pelleted by centrifugation at 4&#x02009;&#x000b0;C and 2,500&#x02009;<bold><italic toggle="yes">g</italic></bold> for 10&#x02009;min, after which the supernatant was discarded. The pellet was resuspended in 20&#x02009;ml of pre-chilled 10% glycerol in distilled water and washed three times. Finally, the pellet was resuspended in 10% glycerol, aliquoted into 50&#x02009;&#x000b5;l portions in pre-chilled cryotubes and stored at &#x02212;80&#x02009;&#x000b0;C.</p><p>In a pre-chilled 1.5-ml microcentrifuge tube, 50&#x02009;&#x000b5;l of electrocompetent cells were mixed with 10&#x02013;100&#x02009;ng of pBACpAK plasmids, and the mixture was transferred to a pre-chilled 0.1-cm electroporation cuvette. Electroporation was performed with the settings of 1.8 kV, 200&#x02009;&#x003a9; and 25&#x02009;&#x000b5;F. After electroporation, 950&#x02009;&#x000b5;l of pre-warmed SOC medium was added to the cells, and the mixture was transferred to a fresh 50-ml tube and incubated at 37&#x02009;&#x000b0;C for 1&#x02009;h. The transformants were then plated on LB agar supplemented with chloramphenicol (to select for pBACpAK) and ampicillin (to select for clinical isolates) to select for successful transformants.</p></sec><sec id="s3-4"><title>Screening for the transformants with MGE insertions on pBACpAK</title><p>The <italic toggle="yes">E. coli</italic> transformants carrying pBACpAK derivatives were subcultured into 5&#x02009;ml of LB medium supplemented with chloramphenicol and ampicillin and incubated at 37&#x02009;&#x000b0;C for 4&#x02009;h. A 500&#x02009;&#x000b5;l aliquot of this culture was then plated on LB agar supplemented with the same antibiotics and tetracycline (MGE screening agar). The remaining culture continued to incubate overnight, after which a 100&#x02009;&#x000b5;l aliquot was plated on MGE screening agar. This process was repeated daily, with the overnight culture used to inoculate new 5&#x02009;ml LB broth, followed by plating and subculturing for an additional 3&#x02009;days. Plates were monitored for colony growth every day for a week, and all resulting colonies were subcultured onto fresh MGE screening agar to confirm their tetracycline resistance phenotype.</p><p>All confirmed tetracycline-resistant clones were initially screened for MGE insertions to confirm they are transposants [<xref rid="R12" ref-type="bibr">12</xref>] in the <italic toggle="yes">cI-tetA</italic> region of pBACpAK using colony PCR with <italic toggle="yes">cI-tetA</italic>-F1 and ERIS primers. The colony PCR was conducted with standard DNA polymerase, which can amplify up to 6&#x02009;kb, to eliminate clones with mutations, insertions, deletions and duplications. Colony PCR was performed using a 10&#x02009;&#x000b5;l reaction consisting of 5&#x02009;&#x000b5;L of 2&#x000d7;MyTaq&#x02009;Red Master Mix (Bioline, UK), 1&#x02009;&#x000b5;l of each primer (10&#x02009;&#x000b5;M) and 3&#x02009;&#x000b5;l of molecular-grade water. PCR conditions were as follows: initial denaturation at 95&#x02009;&#x000b0;C for 10&#x02009;min; followed by 35 cycles of 95&#x02009;&#x000b0;C for 1&#x02009;min, 56.5&#x02009;&#x000b0;C for 30&#x02009;s and 72&#x02009;&#x000b0;C for 3&#x02009;min; and with a final extension at 72&#x02009;&#x000b0;C for 5&#x02009;min.</p><p>Any <italic toggle="yes">cI-tetA</italic> amplicons larger than the WT <italic toggle="yes">cI-tetA</italic> amplicon (1.35&#x02009;kb) were sequenced using the Sanger sequencing service from BNK Bioscience, Thailand. Clones that failed to amplify a product with <italic toggle="yes">cI-tetA</italic>-F1 and ERIS primers were analysed by sequencing through both short- and long-read sequencing. Short-read sequencing was performed by Getz Healthcare, Thailand, using the Illumina HiSeq/NovaSeq platform with a PE150 protocol (2&#x000d7;150&#x02009;bp), while long-read sequencing was performed by using Oxford Nanopore Technologies at Siriraj Translational Microbial Genomics and Data Center (SiTMiD) using MinION with the R10.4.1 flow cell.</p></sec><sec id="s3-5"><title>Bioinformatics analysis on transposant genomes</title><p>The short-read sequencing data was processed using AfterQC to trim and filter low-quality reads (e.g. <italic toggle="yes">Q</italic>&#x0003c;20). For the long-read sequencing data, the Guppy algorithm (version 5.0.7) [<xref rid="R22" ref-type="bibr">22</xref>] was used for the base calling with the HAC (high accuracy) model to convert the raw signals FAST5 to Fastq files; then the adapter was trimmed by Porechop version 0.2.4 [<xref rid="R23" ref-type="bibr">23</xref>]. Assembly was then performed by using the Unicycler version 0.4.8 for hybrid assembly and Flye version v2.9.5 [<xref rid="R24" ref-type="bibr">24</xref><xref rid="R25" ref-type="bibr">25</xref>] for long-read-only assembly. The data from the Sanger sequencing and hybrid assembly were analysed using <sc>blastn</sc>, <sc>blastx</sc> and ISFinder to determine similar matches in the nucleotide, protein and IS element databases, respectively [<xref rid="R26" ref-type="bibr">26</xref><xref rid="R27" ref-type="bibr">27</xref>].</p></sec><sec id="s3-6"><title>Deposition of novel transposons and WGS data of transposants</title><p>A novel transposon was assigned Tn numbers by The Transposon Registry [<xref rid="R28" ref-type="bibr">28</xref>] and designated as Tn<italic toggle="yes">7824</italic> (accession number PV132339). The WGS data have been deposited in the National Center for Biotechnology Information (NCBI) database with accession numbers ranging from SAMN46856268 to SAMN46856290. In addition, the annotated sequences of the modified pBACpAK entrapment vectors have been deposited in GenBank under accession numbers PV591341&#x02013;PV591343.</p></sec></sec><sec sec-type="results" id="s4"><title>Results</title><sec id="s4-1"><title>Construction of the pBACpAK derivatives and introduction into <italic toggle="yes">E. coli</italic> clinical strains</title><p>Three derivatives of the pBACpAK entrapment vector were constructed by adding sequences of 16 and 26 bp upstream of the <italic toggle="yes">cI</italic> gene. These additional nucleotides were incorporated through primers (listed in Table S1, available in the online Supplementary Material) and constructed using the Q5 site-directed mutagenesis kit. The 16&#x02009;bp sequences consisted of the 10&#x02009;bp most commonly found at the 5&#x02032; and 3&#x02032; ends of the IS<italic toggle="yes">26</italic> insertion site, along with the NheI restriction site (Fig. S1). These were named pBACpAK-16bp-5prime and pBACpAK-16bp-3prime, respectively. The 26&#x02009;bp derivative, called pBACpAK-26bp, included the 20&#x02009;bp sequence most commonly found at the 5&#x02032; end of the IS<italic toggle="yes">1</italic> insertion site along with the NheI restriction site. The constructed derivatives were cloned into <italic toggle="yes">E. coli</italic> DH5&#x003b1; and confirmed by Sanger sequencing across the <italic toggle="yes">cI-tetA</italic> region.</p><p>The ESBL <italic toggle="yes">E. coli</italic> strain ESI123 was selected as a model to test the pBACpAK derivatives, as it was sensitive to tetracycline and chloramphenicol, the antibiotics used for screening. WGS analysis of <italic toggle="yes">E. coli</italic> ESI123 revealed that it belongs to sequence type ST410 based on the Achtman MLST scheme, a globally distributed extraintestinal pathogenic <italic toggle="yes">E. coli</italic> lineage commonly associated with antimicrobial resistance [<xref rid="R29" ref-type="bibr">29</xref>]. Screening with VirulenceFinder identified the presence of <italic toggle="yes">fimH</italic>, <italic toggle="yes">fyuA</italic> and <italic toggle="yes">fdeC</italic>, consistent with a uropathogenic <italic toggle="yes">E. coli</italic> pathotype [<xref rid="R30" ref-type="bibr">30</xref>]. The isolate was obtained from a urine sample via an indwelling catheter, indicating a probable urinary tract infection.</p><p>All pBACpAK derivatives, including pBACpAK-WT (the original pBACpAK), pBACpAK-16bp-5prime, pBACpAK-16bp-3prime and pBACpAK-26bp, were introduced through electroporation, as listed in <xref rid="T1" ref-type="table">Table 1</xref>. The inserted sequence in pBACpAK-16bp-5prime site was 5&#x02032;-GCTAGCGTACTCTAAA-3&#x02032;, pBACpAK-16bp-3prime site was 5&#x02032;-GCTAGCTTTAGAGTAC-3&#x02032; and pBACpAK-26bp site was 5&#x02032;-GCTAGCAATATAACCACGATAAGGTA-3&#x02032;, introduced upstream of the <italic toggle="yes">cI</italic> repressor gene.</p></sec><sec id="s4-2"><title>Determining the efficiency of the newly constructed pBACpAK derivatives</title><p><italic toggle="yes">E. coli</italic> ESI123 containing pBACpAK derivatives was subcultured and screened for colonies with a tetracycline resistance phenotype. The number of tetracycline-resistant colonies screened from each strain and the number of confirmed transposants are shown in <xref rid="T2" ref-type="table">Table 2</xref>. It was shown that 3 out of 80 (3.75&#x0200a;%) tetracycline-resistant <italic toggle="yes">E. coli</italic> ESI123::pBACpAK-WT colonies were identified with MGE insertion into the pBACpAK-WT vector. In contrast, the newly constructed pBACpAK derivatives exhibited significantly higher percentages of transposants: 10.7% for pBACpAK-16bp-5Prime, 37.5% for pBACpAK-16bp-3Prime and 73.1% for pBACpAK-26bp. These represent approximately 2.9-fold, 10-fold and 19.5-fold increases in transposition detection efficiency compared to the WT pBACpAK.</p><table-wrap position="float" id="T2"><label>Table 2.</label><caption><title>The number of tetracycline-resistant colonies and transposants found from each pBACpAK derivative</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top" colspan="1">Strains::entrapment vector</th><th rowspan="2" align="center" valign="top" colspan="1">Tetracycline-resistance colony*</th><th colspan="4" align="center" valign="top" rowspan="1">No. of transposant</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1">&#x0003e;2&#x02009;kb insertion</th><th align="center" valign="top" rowspan="1" colspan="1">&#x0003c;2&#x02009;kb insertion</th><th align="center" valign="top" rowspan="1" colspan="1">Total (colony)</th><th align="center" valign="top" rowspan="1" colspan="1">% Transposant</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">E. coli</italic> ESI123::pBACpAK-WT</td><td align="center" valign="top" rowspan="1" colspan="1">80</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">3.75%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">E. coli</italic> ESI123::pBACpAK-16bp-3Prime</td><td align="center" valign="top" rowspan="1" colspan="1">32</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">37.5%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">E. coli</italic> ESI123::pBACpAK-16bp-5Prime</td><td align="center" valign="top" rowspan="1" colspan="1">56</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">10.7%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">E. coli</italic> ESI123::pBACpAK-26bp</td><td align="center" valign="top" rowspan="1" colspan="1">26</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">22</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">73.1%</td></tr></tbody></table><table-wrap-foot><fn id="T2_FN1" fn-type="other"><p>*All tetracycline-resistant colonies were screened by colony PCR across the <italic toggle="yes">cI-tetA</italic> region. Wt-sized amplicons indicated the absence of detectable MGE insertion or integration.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s4-3"><title>Characterization of the MGE insertions in transposants</title><p>Among all transposants, 13 showed an insertion of less than 2&#x02009;kb into the <italic toggle="yes">cI-tetA</italic> region, which were subsequently characterized by Sanger sequencing. The analysis revealed the insertion of two IS elements: IS<italic toggle="yes">1</italic>, in both pBACpAK-WT and the pBACpAK derivatives, and IS<italic toggle="yes">26</italic> in the pBACpAK-16bp-3Prime entrapment vector. Another five colonies showed a 6&#x02009;bp deletion and 14&#x02009;bp duplication within the <italic toggle="yes">cI-tetA</italic> region and had an insertion of an IS<italic toggle="yes">186B</italic> between the <italic toggle="yes">oriV</italic> and the <italic toggle="yes">ori2</italic> of the pBACpAK-WT and the pBACpAK-26bp vector. Surprisingly, none of the insertion sites of any sequenced clones were located in the extra nucleotides added to the pBACpAK-WT. Based on the IS elements, insertion direction and sites, they were categorized into eight different transposition events, as shown in <xref rid="F2" ref-type="fig">Fig. 2</xref>.</p><fig position="float" id="F2" fig-type="figure"><label>Fig. 2.</label><caption><title>Transposants with less than 2&#x02009;kb insertion. The <italic toggle="yes">cI</italic> gene, MGEs, <italic toggle="yes">tetA</italic> and other genes are represented by yellow, blue, green and black open-arrowed boxes, respectively. The additional nucleotides were added at the start of the <italic toggle="yes">cI</italic> repressor gene, indicated by the dashed purple lines.</title></caption><graphic xlink:href="acmi-7-01013-g002" position="float"/></fig><p>The transposants that exhibited no amplicon in the colony PCR screening, often indicating larger insertions, were subsequently characterized through WGS. Among these, 15 out of 28 showed an insertion of an entire 52&#x02009;kb plasmid in the <italic toggle="yes">cI-tetA</italic> region, flanked by two copies of IS<italic toggle="yes">26</italic> on each side. This 52&#x02009;kb plasmid carried by the <italic toggle="yes">E. coli</italic> ESI123 clinical isolate had 99% similarity to the plasmid pJBCDAAC-19&#x02013;0068_OXA-181 previously isolated from <italic toggle="yes">E. coli</italic> (accession number LC778280) [<xref rid="R31" ref-type="bibr">31</xref>]. The structure of the captured element found in these clones conformed to the definition of a composite transposon; thus, it was annotated as Tn<italic toggle="yes">7824</italic>. It contains the carbapenemase resistance gene <italic toggle="yes">bla</italic><sub>OXA-181</sub>, the quinolone resistance gene <italic toggle="yes">qnrS1</italic> and multiple insertion sequences including IS<italic toggle="yes">26</italic>, IS<italic toggle="yes">3000</italic>, IS<italic toggle="yes">Kpn19</italic> and IS<italic toggle="yes">Kox3</italic>. Based on the insertion site and orientation of IS<italic toggle="yes">26</italic>, these Tn<italic toggle="yes">7824</italic>-containing pBACpAK transposants were classified into five different transposition groups, as shown in <xref rid="T3" ref-type="table">Table 3</xref>. <xref rid="F3" ref-type="fig">Fig. 3</xref> shows the structure of the Tn<italic toggle="yes">7824</italic>-pBACpAK cointegrate.</p><table-wrap position="float" id="T3"><label>Table 3.</label><caption><title>The details of MGEs captured by pBACpAK derivatives</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top" colspan="1">Bacterial strain(accession no.)</th><th rowspan="2" align="left" valign="top" colspan="1">MGE/mutation</th><th rowspan="2" align="left" valign="top" colspan="1">Location on pBACpAK (position)</th><th rowspan="2" align="center" valign="top" colspan="1">Size (bp)</th><th colspan="2" align="center" valign="top" rowspan="1">Percentage of similarity (ISFinder/NCBI)</th><th rowspan="2" align="left" valign="top" colspan="1">Direct repeat*</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1">
<sc>blastn</sc>
</th><th align="left" valign="top" rowspan="1" colspan="1">Accession no.</th></tr></thead><tbody><tr><td colspan="7" align="left" valign="top" rowspan="1">
<bold><italic toggle="yes">E. coli</italic> ESI123::pBACpAK-WT</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;D0-ON-3</td><td align="left" valign="top" rowspan="1" colspan="1">IS<italic toggle="yes">1</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">cI</italic> repressor (3089)</td><td align="center" valign="top" rowspan="1" colspan="1">768</td><td align="center" valign="top" rowspan="1" colspan="1">99.7%</td><td align="left" valign="top" rowspan="1" colspan="1">X52534</td><td align="left" valign="top" rowspan="1" colspan="1">GCTAACTTT</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;D0-ON-7,8</td><td align="left" valign="top" rowspan="1" colspan="1">Deletion</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">cI</italic> repressor (3177)</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;</td><td align="left" valign="top" rowspan="1" colspan="1">IS<italic toggle="yes">186B</italic></td><td align="left" valign="top" rowspan="1" colspan="1">Between <italic toggle="yes">oriV</italic> and <italic toggle="yes">ori2</italic> (5831)</td><td align="center" valign="top" rowspan="1" colspan="1">1,338</td><td align="center" valign="top" rowspan="1" colspan="1">99.9%</td><td align="left" valign="top" rowspan="1" colspan="1">X03123</td><td align="left" valign="top" rowspan="1" colspan="1">GGGGTGCCCCC</td></tr><tr><td colspan="7" align="left" valign="top" rowspan="1">
<bold><italic toggle="yes">E. coli</italic> ESI123::pBACpAK-16bp-5Prime</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;D2-ON-4,26</td><td align="left" valign="top" rowspan="1" colspan="1">IS<italic toggle="yes">1</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">cI</italic> repressor (2933)</td><td align="center" valign="top" rowspan="1" colspan="1">768</td><td align="center" valign="top" rowspan="1" colspan="1">99.7%</td><td align="left" valign="top" rowspan="1" colspan="1">X52534</td><td align="left" valign="top" rowspan="1" colspan="1">CACCTTTGG</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;D2-O/N-15, D3-5hr-9,15,20</td><td align="left" valign="top" rowspan="1" colspan="1">IS<italic toggle="yes">1</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">cI</italic> repressor (2731)</td><td align="center" valign="top" rowspan="1" colspan="1">768</td><td align="center" valign="top" rowspan="1" colspan="1">99.7%</td><td align="left" valign="top" rowspan="1" colspan="1">X52534</td><td align="left" valign="top" rowspan="1" colspan="1">TTGAAGGTA</td></tr><tr><td colspan="7" align="left" valign="top" rowspan="1">
<bold><italic toggle="yes">E. coli</italic> ESI123::pBACpAK-16bp-3Prime</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;D3-5hr-2,7</td><td align="left" valign="top" rowspan="1" colspan="1">IS<italic toggle="yes">26</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">cI</italic> repressor (3294)</td><td align="center" valign="top" rowspan="1" colspan="1">820</td><td align="center" valign="top" rowspan="1" colspan="1">99.9%</td><td align="left" valign="top" rowspan="1" colspan="1">X00011</td><td align="left" valign="top" rowspan="1" colspan="1">CTTTTTTG</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;D3-5hr-3,5</td><td align="left" valign="top" rowspan="1" colspan="1">IS<italic toggle="yes">26</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">cI</italic> repressor (2700)</td><td align="center" valign="top" rowspan="1" colspan="1">820</td><td align="center" valign="top" rowspan="1" colspan="1">99.9%</td><td align="left" valign="top" rowspan="1" colspan="1">X00011</td><td align="left" valign="top" rowspan="1" colspan="1">AAAACACC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;D2-5hr-1</td><td align="left" valign="top" rowspan="1" colspan="1">IS<italic toggle="yes">1</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">cI</italic> repressor (2951)</td><td align="center" valign="top" rowspan="1" colspan="1">768</td><td align="center" valign="top" rowspan="1" colspan="1">99.6%</td><td align="left" valign="top" rowspan="1" colspan="1">X52534</td><td align="left" valign="top" rowspan="1" colspan="1">TAAGCTCAG</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;D3-5hr-9</td><td align="left" valign="top" rowspan="1" colspan="1">IS<italic toggle="yes">1</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">cI</italic> repressor (2985)</td><td align="center" valign="top" rowspan="1" colspan="1">768</td><td align="center" valign="top" rowspan="1" colspan="1">96.4%</td><td align="left" valign="top" rowspan="1" colspan="1">X52534</td><td align="left" valign="top" rowspan="1" colspan="1">AGAAAAAA</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">&#x02003;4hrTet-CAT5 &#x02212;9,10,12</td><td align="left" valign="top" rowspan="1" colspan="1">Deletion</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">cI</italic> repressor (1844)</td><td align="center" valign="top" rowspan="1" colspan="1">1,253</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Deletion</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">cI</italic> repressor (3308)</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chromosomal DNA integration flanked by two IS<italic toggle="yes">186B</italic> elements</td><td align="left" valign="top" rowspan="1" colspan="1">Between <italic toggle="yes">oriV</italic> and <italic toggle="yes">ori2</italic> (5831)</td><td align="center" valign="top" rowspan="1" colspan="1">1,338</td><td align="center" valign="top" rowspan="1" colspan="1">99.9%</td><td align="left" valign="top" rowspan="1" colspan="1">X03123</td><td align="left" valign="top" rowspan="1" colspan="1">GGGGTGCCCCC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;4hrTet-CAT5-8</td><td align="left" valign="top" rowspan="1" colspan="1">Tn<italic toggle="yes">7824</italic>(similar to pJBCDAAC-19&#x02013;0068_OXA-181)</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">cI</italic> repressor (2699)</td><td align="center" valign="top" rowspan="1" colspan="1">52,299</td><td align="center" valign="top" rowspan="1" colspan="1">100%</td><td align="left" valign="top" rowspan="1" colspan="1">LC778280</td><td align="left" valign="top" rowspan="1" colspan="1">AAAACACC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;D2-5hr-4</td><td align="left" valign="top" rowspan="1" colspan="1">Tn<italic toggle="yes">7824</italic>(similar to pJBCDAAC-19&#x02013;0068_OXA-181)</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">cI</italic> repressor (2986)</td><td align="center" valign="top" rowspan="1" colspan="1">52,299</td><td align="center" valign="top" rowspan="1" colspan="1">100%</td><td align="left" valign="top" rowspan="1" colspan="1">LC778280</td><td align="left" valign="top" rowspan="1" colspan="1">GTTTTTTC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;D1-ON-18, Tet10-4hr-5</td><td align="left" valign="top" rowspan="1" colspan="1">Chromosomal DNA integration flanked by two IS<italic toggle="yes">1</italic> elements</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">cI</italic> repressor (2985)</td><td align="center" valign="top" rowspan="1" colspan="1">768</td><td align="center" valign="top" rowspan="1" colspan="1">99.7%</td><td align="left" valign="top" rowspan="1" colspan="1">X52534</td><td align="left" valign="top" rowspan="1" colspan="1">TTTTTTCT</td></tr><tr><td colspan="7" align="left" valign="top" rowspan="1">
<bold><italic toggle="yes">E. coli</italic> ESI123::pBACpAK-26bp</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;D2-ON-2,4</td><td align="left" valign="top" rowspan="1" colspan="1">Deletion</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">cI</italic> repressor (2996)</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;</td><td align="left" valign="top" rowspan="1" colspan="1">IS<italic toggle="yes">186B</italic></td><td align="left" valign="top" rowspan="1" colspan="1">Between <italic toggle="yes">oriV</italic> and <italic toggle="yes">ori2</italic> (5831)</td><td align="center" valign="top" rowspan="1" colspan="1">1,338</td><td align="center" valign="top" rowspan="1" colspan="1">99.9%</td><td align="left" valign="top" rowspan="1" colspan="1">X03123</td><td align="left" valign="top" rowspan="1" colspan="1">GGGGTGCCCCC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;D2-ON-5</td><td align="left" valign="top" rowspan="1" colspan="1">Duplication</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">cI</italic> repressor (2963)</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;</td><td align="left" valign="top" rowspan="1" colspan="1">IS<italic toggle="yes">186B</italic></td><td align="left" valign="top" rowspan="1" colspan="1">Between <italic toggle="yes">oriV</italic> and <italic toggle="yes">ori2</italic> (5831)</td><td align="center" valign="top" rowspan="1" colspan="1">1,338</td><td align="center" valign="top" rowspan="1" colspan="1">99.9%</td><td align="left" valign="top" rowspan="1" colspan="1">X03123</td><td align="left" valign="top" rowspan="1" colspan="1">GGGGTGCCCCC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;D3-5hr-1,6</td><td align="left" valign="top" rowspan="1" colspan="1">Tn<italic toggle="yes">7824</italic> (similar to pJBCDAAC-19&#x02013;0068_OXA-181)</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">cI</italic> repressor (2806)</td><td align="center" valign="top" rowspan="1" colspan="1">52,299</td><td align="center" valign="top" rowspan="1" colspan="1">100%</td><td align="left" valign="top" rowspan="1" colspan="1">LC778280</td><td align="left" valign="top" rowspan="1" colspan="1">TTAATTCT</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;D2-5hr-2, D3-ON-1,2,3,4, D3-5hr-3,</td><td align="left" valign="top" rowspan="1" colspan="1">Tn<italic toggle="yes">7824</italic>(similar to pJBCDAAC-19&#x02013;0068_OXA-181)</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">cI</italic> repressor (2985)</td><td align="center" valign="top" rowspan="1" colspan="1">52,299</td><td align="center" valign="top" rowspan="1" colspan="1">100%</td><td align="left" valign="top" rowspan="1" colspan="1">LC778280</td><td align="left" valign="top" rowspan="1" colspan="1">TTTTTTCT</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;D1-ON-1, D1-5hr-1,4</td><td align="left" valign="top" rowspan="1" colspan="1">Tn<italic toggle="yes">7824</italic> (similar to pJBCDAAC-19&#x02013;0068_OXA-181)</td><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">cI</italic> repressor (3000)</td><td align="center" valign="top" rowspan="1" colspan="1">52,299</td><td align="center" valign="top" rowspan="1" colspan="1">100%</td><td align="left" valign="top" rowspan="1" colspan="1">LC778280</td><td align="left" valign="top" rowspan="1" colspan="1">AGTATGAG</td></tr></tbody></table><table-wrap-foot><fn id="T3_FN1" fn-type="other"><p>*The direct repeat represents the target site duplication formed upon insertion of the MGEs identified in each isolate.</p></fn></table-wrap-foot></table-wrap><fig position="float" id="F3" fig-type="figure"><label>Fig. 3.</label><caption><title>Transposant cointegrates with the 52&#x02009;kb plasmid and chromosomal DNA of <italic toggle="yes">E. coli</italic> ESI123 clinical isolate. (<bold>a</bold>) The cointegrate between the pBACpAK derivative and the 52&#x02009;kb plasmid resulted in the formation of Tn<italic toggle="yes">7824</italic>, flanked by IS<italic toggle="yes">26</italic>. (<bold>b</bold>) and (c) The integration of pBACpAK derivative into the host chromosomal DNA flanked by IS<italic toggle="yes">1</italic> and IS<italic toggle="yes">186B</italic>, respectively.</title></caption><graphic xlink:href="acmi-7-01013-g003" position="float"/></fig><p>Additionally, five colonies were found where their pBACpAK derivatives were integrated into <italic toggle="yes">E. coli</italic> chromosomal DNA, flanked by insertion sequences. In <italic toggle="yes">E. coli</italic> ESI123::pBACpAK-16bp-3Prime-D1_ON_18 and D0_4&#x02009;h_5, pBACpAK recombined with chromosomal DNA within the <italic toggle="yes">cI</italic> gene, resulting in the separation of the <italic toggle="yes">cI</italic> gene on each site, flanked by two IS<italic toggle="yes">1</italic> elements. In <italic toggle="yes">E. coli</italic> ESI123::pBACpAK-16bp-3Prime-D0-4hr-9, 10 and 12, the pBACpAK was flanked by two copies of IS<italic toggle="yes">186B</italic>, with recombination occurring between <italic toggle="yes">oriV</italic> and <italic toggle="yes">ori2</italic>, accompanied by a 1.4&#x02009;kb deletion in the <italic toggle="yes">cI</italic> gene.</p></sec></sec><sec sec-type="discussion" id="s5"><title>Discussion</title><p>The results of our study underscore the critical role of MGEs in the dissemination of AMR genes among pathogenic <italic toggle="yes">E. coli</italic> strains. Our findings align with previous reports that MGEs, such as ISs and transposons, facilitate the transposition of resistance determinants, thereby exacerbating the AMR crisis. The construction and utilization of the pBACpAK derivatives, particularly the pBACpAK-16bp-5Prime, pBACpAK-16bp-3Prime and pBACpAK-26bp vectors, demonstrated a higher efficiency in capturing MGE insertions compared to the WT pBACpAK vector. This suggests that the additional nucleotides in these derivatives enhance the detection sensitivity for MGEs. Notably, the insertion rates ranged from 10.7 to 73.1% of tetracycline-resistant colonies, indicating the robustness of these derivatives in identifying active transposition events.</p><p>All tetracycline-resistant colonies were screened by colony PCR to rule out those lacking MGE transposition or chromosomal integration. Colonies that produced WT-sized amplicons likely represent derepression of the <italic toggle="yes">tetA</italic> gene through spontaneous mutations in the <italic toggle="yes">cI</italic> repressor, minor insertions or deletions and small duplications that did not involve canonical transposition events. The relatively high number of tetracycline-resistant colonies investigated for the WT pBACpAK vector, despite its lower transposant percentage of confirmed transposants, could be attributed to the need for a larger screening pool to detect rare insertion events. This approach was taken to ensure transposition activity could be captured, even at low efficiency, and to confirm that the vector remained functionally capable of detecting MGEs.</p><p>Characterization of the MGEs within the transposants revealed a diversity of captured insertion sequences, including IS<italic toggle="yes">1</italic>, IS<italic toggle="yes">26</italic> and IS<italic toggle="yes">186B</italic>, which were all detected by pBACpAK WT previously [<xref rid="R10" ref-type="bibr">10</xref><xref rid="R12" ref-type="bibr">12</xref>]. While the engineered sequences were based on IS<italic toggle="yes">1</italic> and IS<italic toggle="yes">26</italic> target site preferences, the pBACpAK derivatives are not limited to capturing those elements. The detection of IS<italic toggle="yes">186B</italic> demonstrates that these vectors can trap a broader range of MGEs beyond their design templates. In this study, a novel composite transposon Tn<italic toggle="yes">7824</italic> was captured by the pBACpAK derivatives, harbouring <italic toggle="yes">bla</italic><sub>OXA-181</sub> and <italic toggle="yes">qnrS1</italic>, which are associated with resistance to carbapenems and quinolones, respectively. Tn<italic toggle="yes">7824</italic> represents an IS26-mediated integrated plasmid, reinforcing the significance of IS<italic toggle="yes">26</italic> in facilitating the mobilization of large, multidrug-resistant plasmids. This study also represents the first application of the pBACpAK entrapment vector in Thailand, expanding its use beyond previously studied settings. Given Thailand&#x02019;s high burden of AMR and its role as a regional hub for antibiotic use in healthcare and agriculture [<xref rid="R32" ref-type="bibr">32</xref><xref rid="R33" ref-type="bibr">33</xref>], applying this method to local bacterial isolates provides valuable insights into the dynamics of resistance gene dissemination. The successful capture of Tn<italic toggle="yes">7824</italic> further underscores the importance of using entrapment vectors to track emerging MGEs in clinical isolates from this region.</p><p>Our study suggests that the cointegration of pBACpAK and the 52&#x02009;kb plasmid and the integration of the pBACpAK into the chromosomal DNA could be sequential events. This is evidenced by the presence of a single copy insertion of each IS element at the same positions in the transposants with less than 1&#x02009;kb insertions, suggesting that these IS elements first transpose in and subsequently mediate the recombination between the two IS<italic toggle="yes">26</italic>-containing replicons. WGS of the WT <italic toggle="yes">E. coli</italic> ESI123 revealed a single-copy IS element at the insertion site, while two copies were found flanking the plasmid/chromosomal integration sites in these transposants, suggesting that these events could likely occur through homologous recombination or a copy-in mechanism.</p><p>The cointegration between pBACpAK and the 52&#x02009;kb plasmid also illustrates how multidrug resistance plasmids can acquire additional resistance genes through the activity of MGEs, reflecting events that could occur in clinical settings. For instance, a plasmid initially carrying only carbapenemase and quinolone resistance genes could acquire additional resistance genes for chloramphenicol and tetracycline through such recombination events. This exemplifies the dynamic nature of plasmid evolution and the role of MGEs in shaping the resistance profiles of clinical pathogens.</p><p>The integration of pBACpAK derivatives into the <italic toggle="yes">E. coli</italic> chromosomal DNA, particularly within the <italic toggle="yes">cI</italic> gene and between <italic toggle="yes">oriV</italic> and <italic toggle="yes">ori2</italic>, further exemplifies the versatility and impact of MGEs. The observed recombination events, flanked by IS elements, suggest that these sequences can mediate chromosomal integration, potentially leading to stable inheritance of resistance genes. A similar mechanism was reported in a previous study, where the <italic toggle="yes">mcr-1</italic> colistin resistance gene, carried within the Tn<italic toggle="yes">7511</italic> composite transposon flanked by two IS<italic toggle="yes">Apl1</italic> elements, was transferred from the pMCR-E2899 plasmid to the chromosome of <italic toggle="yes">E. coli</italic> DH5&#x003b1; [<xref rid="R10" ref-type="bibr">10</xref><xref rid="R12" ref-type="bibr">12</xref>]. This genetic mechanism can contribute to the persistence and spread of AMR within bacterial populations, even in the absence of selective pressure from antibiotics.</p><p>Interestingly, transposition did not occur at the extra nucleotide sequences added in the construction of the novel entrapment vectors. It was hypothesized that these sequences might act as additional ribosomal binding sites, potentially increasing <italic toggle="yes">cI</italic> gene expression and creating stress conditions that promote transposition. An increase in MGE transposition activity due to stress conditions, such as antibiotic exposure and oxidative stress, has been shown by several studies [<xref rid="R34" ref-type="bibr">34</xref><xref rid="R35" ref-type="bibr">35</xref>]. However, no significant differences in protein expression patterns were observed between <italic toggle="yes">E. coli</italic> ESI123 WT, <italic toggle="yes">E. coli</italic> ESI123::pBACpAK-WT and <italic toggle="yes">E. coli</italic> ESI123::pBACpAK-16bp in our preliminary SDS-PAGE, as shown in Figure S2. However, the lack of observable differences does not rule out subtle effects that could promote transposition.</p><p>Adding extra nucleotides between the promoter and the <italic toggle="yes">cI</italic> repressor gene may provide additional space for the DNA polymerase to bind while still allowing the transposase to catalyse the transposition of insertion sequences into the <italic toggle="yes">cI</italic> repressor gene. In the original configuration, the space between the <italic toggle="yes">cI</italic> repressor gene and the promoter may be too short, such that when RNA polymerase binds to the promoter, there is insufficient space for the transposase to also bind and facilitate insertion. By adding 16&#x02013;26 extra bp in this region, the additional space may allow the transposase to function effectively even when the RNA polymerase is bound. Consequently, the pBACpAK derivatives with these extra nucleotides can be subject to more transposition events. This adjustment potentially alleviates spatial constraints, thus enhancing the overall efficiency of MGE detection. There are examples of previous studies showing that DNA structural features, such as spacing, flexibility and local conformation, can influence transposition activity. For example, IS<italic toggle="yes">1</italic> transposition depends on spacer length, IS<italic toggle="yes">26</italic>-mediated rearrangements are shaped by local DNA structure and Tn<italic toggle="yes">5</italic> activity is affected by DNA bending [<xref rid="R36" ref-type="bibr">36</xref><xref rid="R38" ref-type="bibr">38</xref>]. Additionally, DNA-binding proteins like IHF can enhance IS<italic toggle="yes">1</italic> transposition by promoting DNA bending [<xref rid="R39" ref-type="bibr">39</xref>]. These findings suggest that spacing and accessibility, rather than specific sequences alone, may play a central role in the ability of some MGEs to successfully transpose to an insertion site within cI in the pBACpAK derivatives described here.</p><p>Our study also highlights the limitations of traditional methods for MGE identification, which often rely on phenotypic changes or bioinformatic analysis of WGS data. The entrapment vector approach employed here provides a complementary strategy that positively selects for active transposition events, offering a more comprehensive understanding of MGE dynamics. This method proved effective in detecting both well-characterized and novel MGEs, emphasizing its utility in AMR surveillance and research. Future studies could delve deeper into the underlying mechanisms, exploring whether alternative nucleotide sequences or configurations might better facilitate targeted transposition.</p><p>As a plasmid-based detection system, this approach has certain limitations. The host range may be constrained by the compatibility of the plasmid&#x02019;s origin of replication with the bacterial species of interest. Expanding the application of these derivatives to other pathogens could further demonstrate their versatility and relevance. Our previous work has shown that the current pBACpAK system is functional in <italic toggle="yes">Klebsiella pneumoniae</italic>, suggesting broader compatibility across related taxa [<xref rid="R10" ref-type="bibr">10</xref>]. In addition, the current reliance on chloramphenicol and tetracycline resistance markers restricts use to strains that are susceptible to both antibiotics. However, previous studies have demonstrated that the pBACpAK system can be modified by replacing the <italic toggle="yes">catA1</italic> resistance gene with alternative markers, such as <italic toggle="yes">aph(3&#x02032;)-Ia</italic> or <italic toggle="yes">mcr-1</italic>, enabling its use in strains with different resistance backgrounds [<xref rid="R13" ref-type="bibr">13</xref>].</p><p>In conclusion, the derivatization of the pBACpAK entrapment vectors by adding DNA sequences between the promoter and the cognate gene resulted in increased transposition events. This approach provides a refined method for detecting and characterizing MGEs in multidrug-resistant <italic toggle="yes">E. coli</italic>. These findings contribute to our understanding of the mechanisms facilitating AMR dissemination. Future research should focus on expanding the application of this approach to other clinically relevant pathogens and exploring the potential of MGE-targeted interventions to mitigate the spread of AMR.</p></sec><sec sec-type="supplementary-material" id="s6"><title>Supplementary material</title><supplementary-material id="SF1" position="float" content-type="local-data"><object-id pub-id-type="doi">10.1099/acmi.0.001013.v3</object-id><label>Fig. S1.</label><media xlink:href="acmi-7-01013-s001.pdf" id="d67e1786" position="anchor"/></supplementary-material></sec></body><back><ack><title>Acknowledgements</title><p>The authors would like to thank Professor Mohammed Al-Haroni for providing the <italic toggle="yes">E. coli</italic> strain containing the pBACpAK entrapment vector used in this study. We are also grateful to Mr Perapon Nitayanon for his support as the research assistant overseeing the laboratory. Additionally, we thank the Siriraj Translational Microbial Genomics and Data Center (SiTMiD) for providing the facilities for Oxford Nanopore Technologies (ONT) sequencing.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> This work was financially supported by the Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation (OPS MHESI), Thailand Science Research and Innovation (TSRI) and Mahidol University (grant no. RGNS 65&#x02013;156). This project (STRESST) received funding from the Medical Research Council (MRC), Biotechnology and Biological Sciences Research Council (BBSRC) and Natural Environmental Research Council (NERC), which are all Councils of UK Research and Innovation (Grant no. MR/W030578/1) under the umbrella of the JPIAMR - Joint Programming Initiative on Antimicrobial Resistance.</p></fn><fn fn-type="other"><p><bold>Author contributions:</bold> S.T.: Conceptualization, data curation, formal analysis, funding acquisition, investigation, methodology, project administration, software, supervision, validation, visualization, writing &#x02013; original draft and writing &#x02013; review and editing. W.L.: Conceptualization, data curation, formal analysis, investigation, methodology, project administration, validation and writing &#x02013; review and editing. N.T.: Data curation, formal analysis and writing &#x02013; review and editing. R.N.G.: Methodology, validation and writing &#x02013; review and editing. C.T.: Conceptualization, funding acquisition, methodology, supervision, validation and writing &#x02013; review and editing. A.P.R.: Conceptualization, formal analysis, funding acquisition, investigation, methodology, supervision, validation and writing &#x02013; review and editing.</p></fn></fn-group><notes><def-list><title>Abbreviations</title><def-item><term>AMR</term><def><p>antimicrobial resistance</p></def></def-item><def-item><term>ARGs</term><def><p>antibiotic resistance genes</p></def></def-item><def-item><term>ESBL</term><def><p>extended-spectrum <italic toggle="yes">&#x003b2;</italic>-lactamase</p></def></def-item><def-item><term>HIV</term><def><p>human immunodeficiency virus</p></def></def-item><def-item><term>ISs</term><def><p>insertion sequences</p></def></def-item><def-item><term>LB</term><def><p>Luria&#x02013;Bertani</p></def></def-item><def-item><term>MGEs</term><def><p>mobile genetic elements</p></def></def-item><def-item><term>NCBI</term><def><p>National Center for Biotechnology Information</p></def></def-item><def-item><term>WGS</term><def><p>whole-genome sequencing</p></def></def-item></def-list></notes><ref-list><title>References</title><ref id="R1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Murray</surname><given-names>CJL</given-names></name>
<name><surname>Ikuta</surname><given-names>KS</given-names></name>
<name><surname>Sharara</surname><given-names>F</given-names></name>
<name><surname>Swetschinski</surname><given-names>L</given-names></name>
<name><surname>Robles Aguilar</surname><given-names>G</given-names></name>
</person-group><article-title>Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis</article-title><source>Lancet</source><year>2022</year><volume>399</volume><fpage>629</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)02724-0</pub-id><pub-id pub-id-type="pmid">35065702</pub-id>
</element-citation></ref><ref id="R2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Naghavi</surname><given-names>M</given-names></name>
<name><surname>Vollset</surname><given-names>SE</given-names></name>
<name><surname>Ikuta</surname><given-names>KS</given-names></name>
<name><surname>Swetschinski</surname><given-names>LR</given-names></name>
<name><surname>Gray</surname><given-names>AP</given-names></name>
</person-group><article-title>Global burden of bacterial antimicrobial resistance 1990&#x02013;2021: a systematic analysis with forecasts to 2050</article-title><source>Lancet</source><year>2024</year><volume>404</volume><fpage>1199</fpage><lpage>1226</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(24)01867-1</pub-id><pub-id pub-id-type="pmid">39299261</pub-id>
</element-citation></ref><ref id="R3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Collaborators</surname><given-names>GAR</given-names></name>
</person-group><article-title>Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050</article-title><source>Lancet</source><year>2024</year><volume>404</volume><fpage>1199</fpage><lpage>1226</lpage><comment>20240916</comment><pub-id pub-id-type="doi">10.1016/S0140-6736(24)01867-1</pub-id><pub-id pub-id-type="pmid">39299261</pub-id>
</element-citation></ref><ref id="R4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Manyi-Loh</surname><given-names>C</given-names></name>
<name><surname>Mamphweli</surname><given-names>S</given-names></name>
<name><surname>Meyer</surname><given-names>E</given-names></name>
<name><surname>Okoh</surname><given-names>A</given-names></name>
</person-group><article-title>Antibiotic use in agriculture and its consequential resistance in environmental sources: potential public health implications</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>795</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23040795</pub-id><pub-id pub-id-type="pmid">29601469</pub-id>
</element-citation></ref><ref id="R5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McEwen</surname><given-names>SA</given-names></name>
<name><surname>Collignon</surname><given-names>PJ</given-names></name>
</person-group><article-title>Antimicrobial resistance: a one health perspective</article-title><source>Microbiol Spectr</source><year>2018</year><volume>6</volume><comment>2018/03/31</comment><pub-id pub-id-type="doi">10.1128/microbiolspec.arba-0009-2017</pub-id></element-citation></ref><ref id="R6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tacconelli</surname><given-names>E</given-names></name>
<name><surname>Carrara</surname><given-names>E</given-names></name>
<name><surname>Savoldi</surname><given-names>A</given-names></name>
<name><surname>Harbarth</surname><given-names>S</given-names></name>
<name><surname>Mendelson</surname><given-names>M</given-names></name>
<etal>et al</etal>
</person-group><article-title>Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis</article-title><source>Lancet Infect Dis</source><year>2018</year><volume>18</volume><fpage>318</fpage><lpage>327</lpage><comment>2017/12/26</comment><pub-id pub-id-type="doi">10.1016/S1473-3099(17)30753-3</pub-id><pub-id pub-id-type="pmid">29276051</pub-id>
</element-citation></ref><ref id="R7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Campos</surname><given-names>JC</given-names></name>
<name><surname>da Silva</surname><given-names>MJF</given-names></name>
<name><surname>dos Santos</surname><given-names>PRN</given-names></name>
<name><surname>Barros</surname><given-names>EM</given-names></name>
<name><surname>Pereira</surname><given-names>M de O</given-names></name>
<etal>et al</etal>
</person-group><article-title>Characterization of tn3000, a transposon responsible for blandm-1 dissemination among enterobacteriaceae in brazil, nepal, morocco, and india</article-title><source>Antimicrob Agents Chemother</source><year>2015</year><volume>59</volume><fpage>7387</fpage><lpage>7395</lpage><pub-id pub-id-type="doi">10.1128/AAC.01458-15</pub-id><pub-id pub-id-type="pmid">26392506</pub-id>
</element-citation></ref><ref id="R8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>W</given-names></name>
<name><surname>He</surname><given-names>Z</given-names></name>
<name><surname>Di</surname><given-names>W</given-names></name>
<name><surname>Xu</surname><given-names>W</given-names></name>
<name><surname>Li</surname><given-names>Y</given-names></name>
<etal>et al</etal>
</person-group><article-title>Transposition mechanism of IS Apl1 &#x02014;the determinant of colistin resistance dissemination</article-title><source>Antimicrob Agents Chemother</source><year>2024</year><volume>68</volume><elocation-id>e0123123</elocation-id><pub-id pub-id-type="doi">10.1128/aac.01231-23</pub-id><pub-id pub-id-type="pmid">38289082</pub-id>
</element-citation></ref><ref id="R9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>So&#x00142;yga</surname><given-names>A</given-names></name>
<name><surname>Bartosik</surname><given-names>D</given-names></name>
</person-group><article-title>Entrapment vectors--how to capture a functional transposable element</article-title><source>Pol J Microbiol</source><year>2004</year><volume>53</volume><fpage>139</fpage><lpage>144</lpage><comment>2005/02/1</comment><pub-id pub-id-type="pmid">15702911</pub-id>
</element-citation></ref><ref id="R10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tansirichaiya</surname><given-names>S</given-names></name>
<name><surname>Goodman</surname><given-names>RN</given-names></name>
<name><surname>Guo</surname><given-names>X</given-names></name>
<name><surname>Bulgasim</surname><given-names>I</given-names></name>
<name><surname>Samuelsen</surname><given-names>&#x000d8;</given-names></name>
<etal>et al</etal>
</person-group><article-title>Intracellular transposition and capture of mobile genetic elements following intercellular conjugation of multidrug resistance conjugative plasmids from clinical <italic toggle="yes">Enterobacteriaceae</italic> Isolates</article-title><source>Microbiol Spectr</source><year>2022</year><volume>10</volume><elocation-id>e0214021</elocation-id><comment>20220119</comment><pub-id pub-id-type="doi">10.1128/spectrum.02140-21</pub-id><pub-id pub-id-type="pmid">35044219</pub-id>
</element-citation></ref><ref id="R11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tansirichaiya</surname><given-names>S</given-names></name>
<name><surname>Moyo</surname><given-names>SJ</given-names></name>
<name><surname>Al-Haroni</surname><given-names>M</given-names></name>
<name><surname>Roberts</surname><given-names>AP</given-names></name>
</person-group><article-title>Capture of a novel, antibiotic resistance encoding, mobile genetic element from <italic toggle="yes">Escherichia coli</italic> using a new entrapment vector</article-title><source>J Appl Microbiol</source><year>2021</year><volume>130</volume><fpage>832</fpage><lpage>842</lpage><comment>20200917</comment><pub-id pub-id-type="doi">10.1111/jam.14837</pub-id><pub-id pub-id-type="pmid">32881179</pub-id>
</element-citation></ref><ref id="R12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Goodman</surname><given-names>RN</given-names></name>
<name><surname>Tansirichaiya</surname><given-names>S</given-names></name>
<name><surname>Brouwer</surname><given-names>MSM</given-names></name>
<name><surname>Roberts</surname><given-names>AP</given-names></name>
</person-group><article-title>Intracellular transposition of mobile genetic elements associated with the colistin resistance gene mcr-1</article-title><source>Microbiol Spectr</source><year>2023</year><volume>11</volume><elocation-id>e0327822</elocation-id><comment>20221213</comment><pub-id pub-id-type="doi">10.1128/spectrum.03278-22</pub-id><pub-id pub-id-type="pmid">36511714</pub-id>
</element-citation></ref><ref id="R13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Goodman</surname><given-names>RN</given-names></name>
<name><surname>Tansirichaiya</surname><given-names>S</given-names></name>
<name><surname>Roberts</surname><given-names>AP</given-names></name>
</person-group><article-title>Development of pBACpAK entrapment vector derivatives to detect intracellular transfer of mobile genetic elements within chloramphenicol resistant bacterial isolates</article-title><source>J Microbiol Methods</source><year>2023</year><volume>213</volume><fpage>106813</fpage><comment>2023/08/23</comment><pub-id pub-id-type="doi">10.1016/j.mimet.2023.106813</pub-id><pub-id pub-id-type="pmid">37647945</pub-id>
</element-citation></ref><ref id="R14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Salman</surname><given-names>S</given-names></name>
<name><surname>Umar</surname><given-names>Z</given-names></name>
<name><surname>Xiao</surname><given-names>Y</given-names></name>
</person-group><article-title>Current epidemiologic features and health dynamics of ESBL-producing <italic toggle="yes">Escherichia coli</italic> in China</article-title><source>
<italic toggle="yes">Biosaf Health</italic>
</source><year>2024</year><volume>6</volume><fpage>40</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.bsheal.2024.01.002</pub-id><pub-id pub-id-type="pmid">40078307</pub-id>
</element-citation></ref><ref id="R15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jiang</surname><given-names>H</given-names></name>
<name><surname>Ran</surname><given-names>M</given-names></name>
<name><surname>Wang</surname><given-names>X</given-names></name>
<name><surname>Chen</surname><given-names>Q</given-names></name>
<name><surname>Wang</surname><given-names>J</given-names></name>
<etal>et al</etal>
</person-group><article-title>Prevalence and characterization of class I integrons in multidrug-resistant <italic toggle="yes">Escherichia coli</italic> isolates from humans and food-producing animals in Zhejiang Province, China</article-title><source>BMC Microbiol</source><year>2025</year><volume>25</volume><elocation-id>76</elocation-id><pub-id pub-id-type="doi">10.1186/s12866-025-03794-y</pub-id><pub-id pub-id-type="pmid">39955516</pub-id>
</element-citation></ref><ref id="R16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qing</surname><given-names>Y</given-names></name>
<name><surname>Zou</surname><given-names>Z</given-names></name>
<name><surname>Jiang</surname><given-names>G</given-names></name>
<name><surname>Qin</surname><given-names>L</given-names></name>
<name><surname>Liu</surname><given-names>K</given-names></name>
<etal>et al</etal>
</person-group><article-title>A global perspective on the abundance, diversity and mobility of antibiotic resistance genes in <italic toggle="yes">Escherichia coli</italic></article-title><source>Front Vet Sci</source><year>2024</year><volume>11</volume><fpage>1442159</fpage><pub-id pub-id-type="doi">10.3389/fvets.2024.1442159</pub-id><pub-id pub-id-type="pmid">39606649</pub-id>
</element-citation></ref><ref id="R17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jolley</surname><given-names>KA</given-names></name>
<name><surname>Bray</surname><given-names>JE</given-names></name>
<name><surname>Maiden</surname><given-names>MCJ</given-names></name>
</person-group><article-title>Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications</article-title><source>Wellcome Open Res</source><year>2018</year><volume>3</volume><elocation-id>124</elocation-id><pub-id pub-id-type="doi">10.12688/wellcomeopenres.14826.1</pub-id><pub-id pub-id-type="pmid">30345391</pub-id>
</element-citation></ref><ref id="R18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Malberg Tetzschner</surname><given-names>AM</given-names></name>
<name><surname>Johnson</surname><given-names>JR</given-names></name>
<name><surname>Johnston</surname><given-names>BD</given-names></name>
<name><surname>Lund</surname><given-names>O</given-names></name>
<name><surname>Scheutz</surname><given-names>F</given-names></name>
</person-group><article-title><italic toggle="yes">In Silico</italic> genotyping of <italic toggle="yes">Escherichia coli</italic> isolates for extraintestinal virulence genes by use of whole-genome sequencing data</article-title><source>J Clin Microbiol</source><year>2020</year><volume>58</volume><elocation-id>e01269-20</elocation-id><comment>20200922</comment><pub-id pub-id-type="doi">10.1128/JCM.01269-20</pub-id><pub-id pub-id-type="pmid">32669379</pub-id>
</element-citation></ref><ref id="R19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thompson</surname><given-names>JD</given-names></name>
<name><surname>Higgins</surname><given-names>DG</given-names></name>
<name><surname>Gibson</surname><given-names>TJ</given-names></name>
</person-group><article-title>CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice</article-title><source>Nucleic Acids Res</source><year>1994</year><volume>22</volume><fpage>4673</fpage><lpage>4680</lpage><pub-id pub-id-type="doi">10.1093/nar/22.22.4673</pub-id><pub-id pub-id-type="pmid">7984417</pub-id>
</element-citation></ref><ref id="R20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Crooks</surname><given-names>GE</given-names></name>
<name><surname>Hon</surname><given-names>G</given-names></name>
<name><surname>Chandonia</surname><given-names>J-M</given-names></name>
<name><surname>Brenner</surname><given-names>SE</given-names></name>
</person-group><article-title>WebLogo: a sequence logo generator</article-title><source>Genome Res</source><year>2004</year><volume>14</volume><fpage>1188</fpage><lpage>1190</lpage><comment>2004/06/03</comment><pub-id pub-id-type="doi">10.1101/gr.849004</pub-id><pub-id pub-id-type="pmid">15173120</pub-id>
</element-citation></ref><ref id="R21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dower</surname><given-names>WJ</given-names></name>
<name><surname>Miller</surname><given-names>JF</given-names></name>
<name><surname>Ragsdale</surname><given-names>CW</given-names></name>
</person-group><article-title>High efficiency transformation of <italic toggle="yes">E. coli</italic> by high voltage electroporation</article-title><source>Nucleic Acids Res</source><year>1988</year><volume>16</volume><fpage>6127</fpage><lpage>6145</lpage><pub-id pub-id-type="doi">10.1093/nar/16.13.6127</pub-id><pub-id pub-id-type="pmid">3041370</pub-id>
</element-citation></ref><ref id="R22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wick</surname><given-names>RR</given-names></name>
<name><surname>Judd</surname><given-names>LM</given-names></name>
<name><surname>Holt</surname><given-names>KE</given-names></name>
</person-group><article-title>Performance of neural network basecalling tools for oxford nanopore sequencing</article-title><source>Genome Biol</source><year>2019</year><volume>20</volume><elocation-id>129</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-019-1727-y</pub-id><pub-id pub-id-type="pmid">31234903</pub-id>
</element-citation></ref><ref id="R23"><label>23.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Wick</surname><given-names>R</given-names></name>
<name><surname>Volkening</surname><given-names>J</given-names></name>
<name><surname>Loman</surname><given-names>N</given-names></name>
</person-group><source>Porechop Version 0.2. 4</source><publisher-loc>GitHub repository</publisher-loc><publisher-name>GitHub</publisher-name><year>2018</year></element-citation></ref><ref id="R24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kolmogorov</surname><given-names>M</given-names></name>
<name><surname>Yuan</surname><given-names>J</given-names></name>
<name><surname>Lin</surname><given-names>Y</given-names></name>
<name><surname>Pevzner</surname><given-names>PA</given-names></name>
</person-group><article-title>Assembly of long, error-prone reads using repeat graphs</article-title><source>Nat Biotechnol</source><year>2019</year><volume>37</volume><fpage>540</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1038/s41587-019-0072-8</pub-id><pub-id pub-id-type="pmid">30936562</pub-id>
</element-citation></ref><ref id="R25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wick</surname><given-names>RR</given-names></name>
<name><surname>Judd</surname><given-names>LM</given-names></name>
<name><surname>Gorrie</surname><given-names>CL</given-names></name>
<name><surname>Holt</surname><given-names>KE</given-names></name>
</person-group><article-title>Unicycler: resolving bacterial genome assemblies from short and long sequencing reads</article-title><source>PLoS Comput Biol</source><year>2017</year><volume>13</volume><elocation-id>e1005595</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005595</pub-id><pub-id pub-id-type="pmid">28594827</pub-id>
</element-citation></ref><ref id="R26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Siguier</surname><given-names>P</given-names></name>
<name><surname>Perochon</surname><given-names>J</given-names></name>
<name><surname>Lestrade</surname><given-names>L</given-names></name>
<name><surname>Mahillon</surname><given-names>J</given-names></name>
<name><surname>Chandler</surname><given-names>M</given-names></name>
</person-group><article-title>ISfinder: the reference centre for bacterial insertion sequences</article-title><source>Nucleic Acids Res</source><year>2006</year><volume>34</volume><fpage>D32</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1093/nar/gkj014</pub-id><pub-id pub-id-type="pmid">16381877</pub-id>
</element-citation></ref><ref id="R27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Altschul</surname><given-names>SF</given-names></name>
<name><surname>Gish</surname><given-names>W</given-names></name>
<name><surname>Miller</surname><given-names>W</given-names></name>
<name><surname>Myers</surname><given-names>EW</given-names></name>
<name><surname>Lipman</surname><given-names>DJ</given-names></name>
</person-group><article-title>Basic local alignment search tool</article-title><source>J Mol Biol</source><year>1990</year><volume>215</volume><fpage>403</fpage><lpage>410</lpage><comment>1990/10/05</comment><pub-id pub-id-type="doi">10.1016/S0022-2836(05)80360-2</pub-id><pub-id pub-id-type="pmid">2231712</pub-id>
</element-citation></ref><ref id="R28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tansirichaiya</surname><given-names>S</given-names></name>
<name><surname>Rahman</surname><given-names>MA</given-names></name>
<name><surname>Roberts</surname><given-names>AP</given-names></name>
</person-group><article-title>The transposon registry</article-title><source>Mob DNA</source><year>2019</year><volume>10</volume><elocation-id>40</elocation-id><pub-id pub-id-type="doi">10.1186/s13100-019-0182-3</pub-id><pub-id pub-id-type="pmid">31624505</pub-id>
</element-citation></ref><ref id="R29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pitout</surname><given-names>JDD</given-names></name>
<name><surname>Peirano</surname><given-names>G</given-names></name>
<name><surname>Matsumura</surname><given-names>Y</given-names></name>
<name><surname>DeVinney</surname><given-names>R</given-names></name>
<name><surname>Chen</surname><given-names>L</given-names></name>
</person-group><article-title><italic toggle="yes">Escherichia coli</italic> sequence type 410 with carbapenemases: a paradigm shift within <italic toggle="yes">E. coli</italic> toward multidrug resistance</article-title><source>Antimicrob Agents Chemother</source><year>2024</year><volume>68</volume><elocation-id>e0133923</elocation-id><pub-id pub-id-type="doi">10.1128/aac.01339-23</pub-id><pub-id pub-id-type="pmid">38193668</pub-id>
</element-citation></ref><ref id="R30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Whelan</surname><given-names>S</given-names></name>
<name><surname>Lucey</surname><given-names>B</given-names></name>
<name><surname>Finn</surname><given-names>K</given-names></name>
</person-group><article-title>Uropathogenic <italic toggle="yes">Escherichia coli</italic> (UPEC)-associated urinary tract infections: the molecular basis for challenges to effective treatment</article-title><source>Microorganisms</source><year>2023</year><volume>11</volume><elocation-id>2169</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms11092169</pub-id><pub-id pub-id-type="pmid">37764013</pub-id>
</element-citation></ref><ref id="R31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zuo</surname><given-names>H</given-names></name>
<name><surname>Sugawara</surname><given-names>Y</given-names></name>
<name><surname>Kondo</surname><given-names>K</given-names></name>
<name><surname>Kayama</surname><given-names>S</given-names></name>
<name><surname>Kawakami</surname><given-names>S</given-names></name>
<etal>et al</etal>
</person-group><article-title>Emergence of an incx3 plasmid co-harbouring the carbapenemase genes bla(NDM-5) and bla(OXA-181)</article-title><source>JAC Antimicrob Resist</source><year>2024</year><volume>PubMed Central PMCID</volume><pub-id pub-id-type="doi">10.1093/jacamr/dlae073</pub-id></element-citation></ref><ref id="R32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kongnakorn</surname><given-names>T</given-names></name>
<name><surname>Tichy</surname><given-names>E</given-names></name>
<name><surname>Kengkla</surname><given-names>K</given-names></name>
<name><surname>Kanokwanvimol</surname><given-names>N</given-names></name>
<name><surname>Suthipinijtham</surname><given-names>P</given-names></name>
<etal>et al</etal>
</person-group><article-title>Economic burden of antimicrobial resistance and inappropriate empiric treatment in Thailand</article-title><source>
<italic toggle="yes">Antimicrob Steward Healthc Epidemiol</italic>
</source><year>2023</year><volume>3</volume><elocation-id>e109</elocation-id><pub-id pub-id-type="doi">10.1017/ash.2023.169</pub-id><pub-id pub-id-type="pmid">37502249</pub-id>
</element-citation></ref><ref id="R33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sumpradit</surname><given-names>N</given-names></name>
<name><surname>Wongkongkathep</surname><given-names>S</given-names></name>
<name><surname>Malathum</surname><given-names>K</given-names></name>
<name><surname>Janejai</surname><given-names>N</given-names></name>
<name><surname>Paveenkittiporn</surname><given-names>W</given-names></name>
<etal>et al</etal>
</person-group><article-title>Thailand&#x02019;s national strategic plan on antimicrobial resistance: progress and challenges</article-title><source>Bull World Health Organ</source><year>2021</year><volume>99</volume><fpage>661</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.2471/BLT.20.280644</pub-id><pub-id pub-id-type="pmid">34475603</pub-id>
</element-citation></ref><ref id="R34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yao</surname><given-names>Y</given-names></name>
<name><surname>Maddamsetti</surname><given-names>R</given-names></name>
<name><surname>Weiss</surname><given-names>A</given-names></name>
<name><surname>Ha</surname><given-names>Y</given-names></name>
<name><surname>Wang</surname><given-names>T</given-names></name>
<etal>et al</etal>
</person-group><article-title>Intra- and interpopulation transposition of mobile genetic elements driven by antibiotic selection</article-title><source>
<italic toggle="yes">Nat Ecol Evol</italic>
</source><year>2022</year><volume>6</volume><fpage>555</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1038/s41559-022-01705-2</pub-id><pub-id pub-id-type="pmid">35347261</pub-id>
</element-citation></ref><ref id="R35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>C</given-names></name>
<name><surname>Choo</surname><given-names>K</given-names></name>
<name><surname>Lee</surname><given-names>S-J</given-names></name>
</person-group><article-title>Active transposition of insertion sequences by oxidative stress in <italic toggle="yes">Deinococcus geothermalis</italic></article-title><source>Front Microbiol</source><year>2020</year><volume>11</volume><elocation-id>558747</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2020.558747</pub-id><pub-id pub-id-type="pmid">33224109</pub-id>
</element-citation></ref><ref id="R36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shiga</surname><given-names>Y</given-names></name>
<name><surname>Sekine</surname><given-names>Y</given-names></name>
<name><surname>Ohtsubo</surname><given-names>E</given-names></name>
</person-group><article-title>Transposition of IS1 circles</article-title><source>Genes Cells</source><year>1999</year><volume>4</volume><fpage>551</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2443.1999.00281.x</pub-id><pub-id pub-id-type="pmid">10583504</pub-id>
</element-citation></ref><ref id="R37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>He</surname><given-names>S</given-names></name>
<name><surname>Hickman</surname><given-names>AB</given-names></name>
<name><surname>Varani</surname><given-names>AM</given-names></name>
<name><surname>Siguier</surname><given-names>P</given-names></name>
<name><surname>Chandler</surname><given-names>M</given-names></name>
<etal>et al</etal>
</person-group><article-title>Insertion Sequence IS26 reorganizes plasmids in clinically isolated multidrug-resistant bacteria by replicative transposition</article-title><source>mBio</source><year>2015</year><volume>6</volume><elocation-id>e00762</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.00762-15</pub-id><pub-id pub-id-type="pmid">26060276</pub-id>
</element-citation></ref><ref id="R38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>York</surname><given-names>D</given-names></name>
<name><surname>Reznikoff</surname><given-names>WS</given-names></name>
</person-group><article-title>DNA binding and phasing analyses of Tn5 transposase and a monomeric variant</article-title><source>Nucleic Acids Res</source><year>1997</year><volume>25</volume><fpage>2153</fpage><lpage>2160</lpage><pub-id pub-id-type="doi">10.1093/nar/25.11.2153</pub-id><pub-id pub-id-type="pmid">9153315</pub-id>
</element-citation></ref><ref id="R39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kopkowski</surname><given-names>PW</given-names></name>
<name><surname>Zhang</surname><given-names>Z</given-names></name>
<name><surname>Saier</surname><given-names>MH</given-names></name>
</person-group><article-title>The effect of DNA-binding proteins on insertion sequence element transposition upstream of the <italic toggle="yes">bgl</italic> operon in <italic toggle="yes">Escherichia coli</italic></article-title><source>Front Microbiol</source><year>2024</year><volume>15</volume><fpage>1388522</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2024.1388522</pub-id><pub-id pub-id-type="pmid">38666260</pub-id>
</element-citation></ref></ref-list></back></article>